How to start the weight loss process with peptides or drugs Ozempic/Wegovy/Mounjaro/Reta/Cargi?

How to start the weight loss process with peptides or drugs Ozempic/Wegovy/Mounjaro/Reta/Cargi?

1. Perform laboratory tests

WOMEN:

For menstruating women, tests should be performed between days 3 and 5 of the cycle, for non-menstruating women, on any day.

• Morphology,
• OGTT 0-60-120 min for glucose with insulin (requires referral) / alternatively, a blood glucose and insulin test can be performed
• HbA1c
• Ferritin/B12/Folic Acid
• Lipid profile
• Uric acid
• ALT/AST/GGTP
• TSH/FT3/FT4/ATPO and ATG
• AMH
• Estradiol
• FSH
• LH
• Prolactin
• Androstenedione
• Creatinine
• eGFR
• D-dimers

MEN:

• Free testosterone
• Total testosterone
• Estradiol
• FSH/LH/ALT/AST/GGTP
• OGTT 0-60-120 min for glucose with insulin (requires referral) / alternatively, a blood glucose and insulin test can be performed
• HbA1c
• Uric acid
• B12/ferritin/folic acid
• Morphology
• TSH/FT3/FT4/ATPO and ATG
• Prolactin
• Lipid profile
• Creatinine
• eGFR
• D-dimers

You cannot have any deviations from the norm in the above tests, especially in the field of pancreas, liver and sugar metabolism.

2. Determining the type of obesity – overweight

Obesity is a complex health problem that can be classified in different ways. One popular method of classification is the use of the body mass index (BMI), but there are also other categories and classification methods that take into account other factors such as body fat distribution, body circumference, waist-to-hip ratio, etc. Below is the classification of obesity in women and men, taking into account both BMI and other factors:

Classification of obesity by BMI:

1. **Type I obesity:**

• **BMI:** 30.0–34.9 kg/m² (class I)
• **Diagnosis:** The presence of excess body fat, confirmed by measurement of body mass index.

2. **Type II obesity:**

• **BMI:** 35.0–39.9 kg/m² (class II)
• **Diagnosis:** Significant health risk associated with obesity, defined by a high BMI and the presence of related diseases.

3. **Type III obesity (extreme):**

• **BMI:** above 40.0 kg/m² (class III)
• **Diagnosis:** Extreme health risk requiring urgent treatment and management.

Classification of obesity according to fat distribution:

1. **Apple-shaped obesity:**

• **Characteristics:** Increased amount of fat tissue around the abdomen, leading to an „apple shape”.
• **Diagnosis:** Men with a waist circumference greater than 102 cm, women with a waist circumference greater than 88 cm.

2. **Pear-shaped obesity:**

• **Characteristics:** Increased fat tissue in the hips and thighs, leading to a „pear shape.”
• **Diagnosis:** Men and women with large hip circumference and a waist-to-hip ratio of less than 0.85 (in women) or 0.90 (in men).

Classification of obesity according to the distribution of fat in the body:

1. **Gynoid obesity:**

• **Characteristics:** Excessive amount of fat located around the hips and thighs.
• **Diagnosis:** Visible increase in circumference of the hips and buttocks.

2. **Android obesity:**

• **Characteristics:** Excessive amount of fat located around the belly and chest area.
• **Diagnosis:** Visible increase in waist circumference.

The classification of obesity in women and men may be similar, but differences in fat distribution and other factors may lead to subtle differences in diagnosis and treatment approaches. It is worth emphasizing that the diagnosis and treatment of obesity should always be conducted by medical professionals.

3. Selection of peptides depending on the situation from points 1 and 2

Assuming that you have all the tests within the norm, below are the schemes used by other people. Before starting the therapy, you should take body measurements in the chest, abdomen, hips, thighs and take a starting weight measurement

• Gynoid obesity (description above):

Week 1-4 TIRZ 5 mg once a week

weekly on an empty stomach on the same day weight control, after 4 weeks verification of circumferences, if a decrease is noticeable 5-10 weeks TIRZ 5 mg once a week, if there are no effects, next step:

5-10 weeks TIRZ 10 mg once a week

weekly fasting on the same day weight control, after 4 weeks verification of circumferences, if a decrease is noticeable 10-15 weeks TIRZ 10 mg once a week.

• Android obesity (description above):

Week 1-4 TIRZ 5 mg once a week (e.g. Saturday)

Week 1-4 RETA 5 mg once a week (e.g. Wednesday)

weekly on an empty stomach on the same day weight control, after 4 weeks verification of circumferences, if a decrease is noticeable 5-10 weeks TIRZ 5 mg and RETA 5 mg once a week, if there are no effects, next step:

Week 5-10 of TIRZ 10 mg once a week (e.g. Saturday)

Week 5-10 RETA 5 mg once a week (e.g. Wednesday)

weekly fasting on the same day weight control, after 4 weeks verification of circumferences, if a decrease is noticeable 10-15 weeks TIRZ 10 mg once a week.

This is not medical advice, you should consult any drug use regimen with your doctor!

Admin

All Author Posts